NovaBridge Biosciences Income (Loss) from Continuing Operations before Income Taxes, Domestic
NovaBridge Biosciences (NBP) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$9.02 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-04-07
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$9.02M 20-F · filed 2026-04-07 |
| 2024-12-31 | $8.91M 20-F · filed 2026-04-07 |
| 2023-12-31 | -$48.90M 20-F · filed 2026-04-07 |